Atea Pharmaceuticals, Inc. AVIR
Set alert
4.11 USD -0.20 -4.64%
At close · Oct 30
4.11 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
4.07 Day range 4.32
2.87 52-week range 6.45
- YTD
- +15.13%
- 1 year
- +25.69%
- Open
- 4.30
- Prev close
- 4.31
- Mkt cap
- 329.64M
- Vol
- 349.86K
- Avg vol
- 280.24K
- EPS
- -2.09
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.07
- High
- 4.32
- Forward P/E
- -2.12
- Beta
- 0.17
- Short ratio
- 14.25
- Inst. own
- 71.14%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 3.31
- 200-d avg
- 3.59
- 1y target
- 7.40
Financial health
Altman Z-Score
2.01 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -1.8×
FY 2018 5y median -1.8× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.1×
FY 2018 5y median 0.6× FY 2025
P/FCF -2.2×
FY 2018 5y median -3.0× FY 2025
EV/EBITDA -1.2×
FY 2018 5y median -0.9× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -45.4%
FY 2018 5y median -33.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -57.5%
FY 2018 5y median -24.5% FY 2025
ROIC -63.0%
FY 2018 5y median -29.1% FY 2025
ROA -50.2%
FY 2018 5y median -22.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 6.3%
FY 2018 FY 2025
EPS (diluted) 3.0%
FY 2018 FY 2025
Free Cash Flow 2.6%
FY 2018 FY 2025
Financial Health
Current Ratio 7.8×
FY 2018 5y median 18.2× FY 2025
Quick Ratio 7.8×
FY 2018 5y median 18.2× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2018 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31